Allogenic mouse cell vaccine inhibits lung cancer progression by inhibiting angiogenesis

Allogenic mouse cell vaccine inhibits lung cancer progression by inhibiting angiogenesis

Aim: This research investigated the therapeutic effect of an allogeneic mouse brain microvascular endothelial cell vaccine on lung cancer and further elucidated its potential anti-angiogenic mechanism. Materials & methods: The immune effect of the allogeneic bEnd.3 vaccine and DC vaccine loaded...

Full description

Bibliographic Details
Main Authors: Jun Zhao, Xiaoling Zhang, Yunyi Du, Lurong Zhou, Ziming Dong, Jimin Zhao, Jing Lu
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
vaccine
allogeneic
vascular endothelial cells
anti-angiogenesis
dendritic cells
immunotherapy
Online Access:http://dx.doi.org/10.1080/21645515.2020.1759996

Similar Items

Similar Items